Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Results

Collegium Pharmaceutical Beats on EPS, Stock Down 0.5%

Collegium Pharmaceutical reported a strong EPS of $1.45, exceeding expectations by 6.62%. However, the stock reacted negatively, declining by 0.5% on the day. The lack of revenue data and management commentary may have contributed to investor uncertainty.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.45	N/A	+6.62%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Collegium Pharmaceutical Beats on EPS, Stock Down 0.5%

Key numbers

Management commentary

Collegium Pharmaceutical, Inc.

More earnings this week

Collegium Pharmaceutical Beats on EPS, Stock Down 0.5%

Key numbers

Management commentary